.svg){kind=small}
Driving innovation
in clinical research
.png)
At the forefront of drug evolution
Leading the way in First-in-Human studies with a variety of patient populations.
Take your asset from First-in-Human to Proof of Concept in under one year with our specialist services.
Take your asset from First-in-Human to Proof of Concept in under one year with our specialist services.
Thorough QT Studies
.svg)
Take your asset from FIH to POC in under one year using our specialist services.
-min.jpg)
We are Richmond Pharmacology.
We are committed to advancing science and driving innovations in drug development.
We reduce drug development timelines using knowledge and expertise accumulated from over 500 clinical trials.
We reduce drug development timelines using knowledge and expertise accumulated from over 500 clinical trials.
Work with us
We work with leading genetic engineering organisations, top 10 pharma companies and dynamic biotechs to assess the safety and efficacy of new therapeutics.
By working with us, you will gain a research partner who can expedite your study start up, enable fast decisions and reduce your drug development timelines.
-min.jpg)
.jpg)
Latest news
Richmond Pharmacology Announces Promotion of Dr Priscilla Ochuba to Associate Medical Director
August 1, 2025
Richmond Pharmacology is pleased to announce the promotion of Dr Priscilla Ochuba to Associate Medical Director, effective 1st August 2025.
Read moreRed4Research Blog – Alan’s Story
June 24, 2025
#Red4Research is a global initiative that recognises the essential role of clinical research in improving treatment, outcomes, and the future of medicine.
Read moreEvents
JSCPT 2025
5th –6th December 2025
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
View event
